Benda, M.; Reimann, P.; Bletzacher, E.; Muendlein, A.; Bernhard, B.; Hartmann, B.; Huynh, M.; Gasser, K.; Zojer, N.; Lang, T.;
et al. Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q. Cancers 2025, 17, 1261.
https://doi.org/10.3390/cancers17081261
AMA Style
Benda M, Reimann P, Bletzacher E, Muendlein A, Bernhard B, Hartmann B, Huynh M, Gasser K, Zojer N, Lang T,
et al. Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q. Cancers. 2025; 17(8):1261.
https://doi.org/10.3390/cancers17081261
Chicago/Turabian Style
Benda, Magdalena, Patrick Reimann, Elena Bletzacher, Axel Muendlein, Benda Bernhard, Bernd Hartmann, Minh Huynh, Klaus Gasser, Niklas Zojer, Theresia Lang,
and et al. 2025. "Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q" Cancers 17, no. 8: 1261.
https://doi.org/10.3390/cancers17081261
APA Style
Benda, M., Reimann, P., Bletzacher, E., Muendlein, A., Bernhard, B., Hartmann, B., Huynh, M., Gasser, K., Zojer, N., Lang, T., Göbel, G., Bohn, J.-P., Schmidt, S., Gunsilius, E., Nachbaur, D., Jukic, E., Locher, M., Willenbacher, E., Willenbacher, W.,
... Steiner, N.
(2025). Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q. Cancers, 17(8), 1261.
https://doi.org/10.3390/cancers17081261
